Published Date: 31-Oct-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Cardiac Catheters & Guidewires Market size is expected to reach $19 billion by 2028, rising at a market growth of 7.4% CAGR during the forecast period.
The Cardiac Catheters market acquired maximum revenue share in the Global Cardiac Catheters & Guidewires Market by Product in 2021; thereby, achieving a market value of $15 billion by 2028. Cardiac catheters are typically used to unlock blood vessels that have been clogged, improving blood flow. When injected inside blood vessels, it expands and causes an increase in blood flow. Cardiac catheters are mostly utilized in interventional procedures like angioplasty, PCI, and cardiac catheterization.
The Ambulatory Surgical Centers market is exhibiting the highest CAGR of 8% during (2022 - 2028). Patients who are undergoing less involved surgeries that only require a brief hospital stay typically choose ambulatory surgery facilities, also known as outpatient surgery centers. With minimally invasive interventional procedures, which also entail a brief hospital stay, rapid healing is achievable. As a result, patients choosing such procedures typically prefer ASCs.
The North America market dominated the Global Cardiac Catheters & Guidewires Market by Region in 2021; thereby, achieving a market value of $7.5 billion by 2028. The Europe market is exhibiting a CAGR of 7.1% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 8.4% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Biotronik SE & Co. KG, Medtronic PLC, Nipro Corporation, Merit Medical Systems, Inc., Teleflex, Inc. and B. Braun Melsungen AG
By End User
Unique Offerings from KBV Research